1. Home
  2. Paclitaxel
  Subject:

Paclitaxel   New Search

View on DBpedia    View on Wikipedia
Top related subjects:
RELATED SUBJECTS:
The publications listed also have these subjects
Chemotherapy  26 times
Breast cancer  14 times
Carboplatin  12 times
Pharmacokinetics  6 times
Neutropenia  6 times
Neu!  6 times
Doxorubicin  6 times
Cyclophosphamide  6 times
Apoptosis  6 times
Metastasis  5 times
Gene  5 times
Cisplatin  5 times
Carcinoma  5 times
Trastuzumab  4 times
Transmission electron microscopy  4 times
Radiation therapy  4 times
Protein  4 times
Progression-free survival  4 times
Ovarian cancer  4 times
Multivariate analysis  4 times
MCF-7  4 times
Adjuvant  4 times
Tubulin  3 times
Stomach cancer  3 times
Peripheral neuropathy  3 times
P53  3 times
Metabolism  3 times
List of breast cancer cell lines  3 times
High-performance liquid chromatography  3 times
Fluorouracil  3 times
Etoposide  3 times
Estrogen receptor  3 times
Diarrhea  3 times
Capecitabine  3 times
Xenotransplantation  2 times
Western blot  2 times
Thrombocytopenia  2 times
TNBC  2 times
Protein kinase B  2 times
P-glycoprotein  2 times
Neoadjuvant therapy  2 times
Nanoparticle  2 times
Myalgia  2 times
Munhwa Broadcasting Corporation  2 times
Messenger RNA  2 times
Iodide  2 times
Immunotherapy  2 times
Immunohistochemistry  2 times
Ifosfamide  2 times
IC50  2 times
Hydrophobe  2 times
Hormone  2 times
Growth factor  2 times
Gastrectomy  2 times
Fourier-transform infrared spectroscopy  2 times
Flow cytometry  2 times
Fever  2 times
Enzyme inhibitor  2 times
Enzyme  2 times
Dispersity  2 times
DNA  2 times
Cytochrome P450  2 times
Creatine kinase  2 times
Clinical trial  2 times
Cervical cancer  2 times
Cell cycle  2 times
Biopsy  2 times
Biomarker  2 times
Bcl-2  2 times
Ant colony  2 times
Agar  2 times
Adjuvant therapy  2 times
Adenocarcinoma  2 times
Zeta potential  1 time
Virtual screening  1 time
Triple-negative breast cancer  1 time
Taxane  1 time
Taiwan  1 time
TUNEL assay  1 time
Stomatitis  1 time
Stomach  1 time
Stent  1 time
Stem cell  1 time
Sponge  1 time
Sorafenib  1 time
Somatic cell  1 time
Single-nucleotide polymorphism  1 time
Silicon dioxide  1 time
Sepsis  1 time
Senescence  1 time
Salivary gland  1 time
Rhabdomyolysis  1 time
Prostaglandin-endoperoxide synthase 2  1 time
Prime Time Entertainment Network  1 time
Polyploid  1 time
Polymerization  1 time
Polymer  1 time
Polycaprolactone  1 time
Plasmid  1 time
Phylogenetics  1 time
Phenotype  1 time
Pharmacodynamics  1 time
Personal protective equipment  1 time
Peroxide  1 time
Peritoneum  1 time
Performance status  1 time
Pancreatic islets  1 time
PH  1 time
P110α  1 time
Orbit  1 time
Odds ratio  1 time
Nuclear magnetic resonance spectroscopy  1 time
Non-small-cell lung carcinoma  1 time
Natural product  1 time
NCI-60  1 time
Mouse  1 time
Monoclonal antibody  1 time
Mitomycins  1 time
Mitogen-activated protein kinase  1 time
Milan  1 time
Methotrexate  1 time
Metabolomics  1 time
Mesoporous silica  1 time
Melphalan  1 time
Melanoma  1 time
Mass spectrometry  1 time
Magnesium  1 time
MTT assay  1 time
Lymphovascular invasion  1 time
Lymph node  1 time
Lung cancer  1 time
Lumbar vertebrae  1 time
Lipoprotein  1 time
Lipid  1 time
Leukopenia  1 time
LaTeX  1 time
Kinase  1 time
Italy  1 time
Iron(III) chloride  1 time
Irinotecan  1 time
Iran  1 time
Interim analysis  1 time
Institutional review board  1 time
In Essence  1 time
Immunofluorescence  1 time
Hypothermia  1 time
Hypokalemia  1 time
Hyperthermic intraperitoneal chemotherapy  1 time
Hyperglycemia  1 time
Hydrophile  1 time
Hydrogen bond  1 time
Human serum albumin  1 time
Hsp90  1 time
Hospital  1 time
Homologous recombination  1 time
Histology  1 time
Hemolysis  1 time
Hematopoietic stem cell transplantation  1 time
Hair loss  1 time
Glioblastoma multiforme  1 time
Germ cell tumor  1 time
Genome  1 time
Gene ontology  1 time
Gelatin  1 time
Gastrointestinal tract  1 time
Fungus  1 time
Fungal isolate  1 time
Folic acid  1 time
Fermentation  1 time
Exon  1 time
Exome sequencing  1 time
Everolimus  1 time
Esophageal cancer  1 time
Epithelium  1 time
Endophyte  1 time
Electron transport chain  1 time
EP300  1 time
Dyslipidemia  1 time
Dynamic light scattering  1 time
Diabetes mellitus type 2  1 time
Dexamethasone  1 time
Debulking  1 time
DNA microarray  1 time
Cytotoxicity  1 time
Cytoplasm  1 time
Cytopathology  1 time
Critical micelle concentration  1 time
Coronary artery disease  1 time
Contact angle  1 time
Confocal microscopy  1 time
Confidence interval  1 time
Colorectal cancer  1 time
Colchicine  1 time
Cluster analysis  1 time
Clopidogrel  1 time
ClinicalTrials.gov  1 time
Classical music  1 time
Classical mechanics  1 time
Cladosporium  1 time
Chromosome  1 time
Cholesterol  1 time
Chitosan  1 time
Chemotherapy regimen  1 time
Caspase 3  1 time
Cardiovascular disease  1 time
Carcinoembryonic antigen  1 time
Carboxylic acid  1 time
Carbon  1 time
Cadherin  1 time
Caco-2  1 time
CT scan  1 time
CD8  1 time
CD44  1 time
C-reactive protein  1 time
Blood plasma  1 time
Biology  1 time
Binding energy  1 time
Bayesian network  1 time
BRCA1  1 time
Aspirin  1 time
Aspergillus fumigatus  1 time
Antiplatelet drug  1 time
Antiemetic  1 time
Anorexia nervosa  1 time
Annexin  1 time
Aneuploidy  1 time
Anemia  1 time
Amphiphile  1 time
Alkaloid  1 time
Algorithm  1 time
Aircraft fabric covering  1 time
Adsorption  1 time
Acetone  1 time
ABCG2  1 time

Publications tagged with this subject: 50

Note: Top 50 publications shown only. Open an item panel to view more info


1. New chemotherapies in breast cancer

2. Vitreous Humor Metastasis in Squamous Cell Carcinoma of Cervix

3. Effect of Paclitaxel-Mesoporous Silica Nanoparticles with a Core-Shell Structure on the Human Lung Cancer Cell Line A549

4. A phase II study of REOLYSIN® (pelareorep) in combination with carboplatin and paclitaxel for patients with advanced malignant melanoma

5. Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer

6. Increased risk of paclitaxel-induced peripheral neuropathy in patients using clopidogrel: a retrospective pilot study

7. New chemotherapies in gastric adenocarcinoma

8. Efficacy and safety of nab-paclitaxel 125 mg/m2 and nab-paclitaxel 150 mg/m2 compared to paclitaxel in early high-risk breast cancer. Results from the neoadjuvant randomized GeparSepto study (GBG 69)

9. Solitary choroidal metastasis from gastric adenocarcinoma: a case report

10. Phase I dose escalation and pharmacokinetic study on the nanoparticle formulation of polymeric micellar paclitaxel for injection in patients with advanced solid malignancies

11. Systematic review and network meta-analysis comparing palbociclib with chemotherapy agents for the treatment of postmenopausal women with HR-positive and HER2-negative advanced/metastatic breast cancer

12. Activity of weekly paclitaxel−cetuximab chemotherapy in unselected patients with recurrent/metastatic head and neck squamous cell carcinoma: prognostic factors

13. Chemotherapeutic dosing implicated by pharmacodynamic modeling of in vitro cytotoxic data: a case study of paclitaxel

14. Paclitaxel-loaded hollow-poly(4-vinylpyridine) nanoparticles enhance drug chemotherapeutic efficacy in lung and breast cancer cell lines

15. Discovery of Therapeutic Lead Molecule Against β-Tubulin Using Computational Approach

16. Psoas muscle volume as a predictor of peripheral neurotoxicity induced by primary chemotherapy in ovarian cancers

17. Synthesis and characterization of chitosan-grafted-polycaprolactone micelles for modulate intestinal paclitaxel delivery

18. Isolation of isoxanthanol and synthesis of novel derivatives as potential cytotoxic agents

19. Lycorine inhibits breast cancer growth and metastasis via inducing apoptosis and blocking Src/FAK-involved pathway

20. A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer

21. Antitumor activity and safety profile of weekly carboplatin plus paclitaxel in metastatic breast cancer: a ten-year, monocentric, retrospective study

22. TAK-228 (formerly MLN0128), an investigational dual TORC1/2 inhibitor plus paclitaxel, with/without trastuzumab, in patients with advanced solid malignancies

23. Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer

24. Coronary Stents in Diabetic Patients: State of the Knowledge

25. Peritoneal Lavage CEA mRNA Levels Predict Conversion Gastrectomy Outcomes after Induction Chemotherapy with Intraperitoneal Paclitaxel in Gastric Cancer Patients with Peritoneal Metastasis

26. Production of paclitaxel with anticancer activity by two local fungal endophytes, Aspergillus fumigatus and Alternaria tenuissima

27. Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy

28. Induction of accelerated senescence by the microtubule-stabilizing agent peloruside A

29. Development of an acetone/water fractional precipitation process for purification of paclitaxel from plant cell cultures

30. Uterine Papillary Serous Carcinoma—Still an Enigma?

31. Preparation and characterization of superparamagnetic Fe3O4/CNTs nanocomposites dual-drug carrier

32. BRCA1-like profile is not significantly associated with survival benefit of non-myeloablative intensified chemotherapy in the GAIN randomized controlled trial

33. A phase I study of cilengitide and paclitaxel in patients with advanced solid tumors

34. Isolation of Taxol-Producing Endophytic Fungi from Iranian Yew Through Novel Molecular Approach and Their Effects on Human Breast Cancer Cell Line

35. Plant diterpenoid metabolism for manufacturing the biopharmaceuticals of tomorrow: prospects and challenges

36. Hardly water-soluble drug-loaded gelatin nanoparticles sustaining a slow release: preparation by novel single-step O/W/O emulsion accompanying solvent diffusion

37. Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy.

38. High PTEN gene expression is a negative prognostic marker in human primary breast cancers with preserved p53 function

39. Induced Aneugenic Effects in Mouse Oocytes In Vivo

40. Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report

41. PIK3CA mutations and TP53 alterations cooperate to increase cancerous phenotypes and tumor heterogeneity

42. Short infusion of paclitaxel imbalances plasmatic lipid metabolism and correlates with cardiac markers of acute damage in patients with breast cancer

43. Tolerability and efficacy of concurrent chemoradiotherapy comparing carboplatin/paclitaxel versus platinum/5-FU regimen for locally advanced esophageal and esophagogastric junction cancers

44. Evaluation of the permeation of antineoplastic agents through medical gloves of varying materials and thickness and with varying surface treatments

45. A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO)

46. Kuguacin J isolated from bitter melon leaves modulates paclitaxel sensitivity in drug-resistant human ovarian cancer cells

47. Myoepithelial carcinoma with RB1 mutation: remarkable chemosensitivity to carcinoma of unknown origin therapy

48. Effectiveness of antiemetic triplet therapy with aprepitant, palonosetron, and dexamethasone for gynecologic cancer patients receiving carboplatin and paclitaxel: a prospective single-arm study

49. Longitudinal perceptions of the side effects of chemotherapy in patients with gynecological cancer

50. High Penetration of Paclitaxel in Abdominal Wall of Rabbits after Hyperthermic Intraperitoneal Administration of Nab-Paclitaxel Compared to Standard Paclitaxel Formulation


Questions?

Drop us a message.